RVTY · NYSE · STOCK
Revvity (RVTY) Stock Analysis
$154.12
52W $81.22 – $166.25
54/100
$17.20B
73.4
1.06
Is RVTY Bullish or Bearish?
Mixed.
Innellis AI committee rates Revvity (RVTY) Watch with a composite score of 54/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +6.46 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -13.54 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 72.6 is expensive by classic value standards — Value
- ROE of only 3.3% -- cheap may mean cheap for a reason — Value
- EPS declining -10.8% YoY despite any revenue growth — Growth
- MACD histogram negative -- bearish momentum — Technical
- Weekly RSI at 86 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 17.9% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
54/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 74%
of 192 Healthcare peers
Value Analyst
neutral
44
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 72.6 is expensive by classic value standards
Growth Analyst
neutral
56
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 5 consecutive earnings beats -- consistent execution
− EPS declining -10.8% YoY despite any revenue growth
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 17.9% signals elevated volatility
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
60
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 53.5 to 53.5.
- New bearish signals: 3 appeared.
- Bearish pressure eased: 3 signal(s) disappeared.
- Analyst(s) changed stance: News Analyst.
Analyst-level changes:
- News Analyst: stance neutral->bullish.
- Risk Analyst: +1 bearish signal(s).
- Technical Analyst: +1 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
63.1
Neutral
MACD Histogram
-0.414
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.72
Inside Bands
Price vs Moving Averages
EMA 9
$152.19
Above
EMA 21
$146.69
Above
EMA 50
$135.25
Above
EMA 200
$113.00
Above
Fundamental Analysis
Valuation
62
Growth
78
Profitability
39
Financial Health
92
Cash Flow
70
Valuation
P/E Ratio
73.4×
P/B Ratio
2.38×
PEG Ratio
-6.66
Dividend Yield
0.18%
52W High
$166.25
52W Low
$81.22
Quality & Growth
ROE
333.3%
ROA
198.6%
Gross Margin
5210.7%
Operating Margin
1232.4%
Revenue Growth YoY
—
Debt / Equity
0.46
AI Fundamental Assessment
P/E ratio of 73.4 (rich relative to a 15-40x range); Price-to-book of 2.4x; PEG ratio of -6.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 3.3%; Return on assets of 2.0%; Net margin of 8.2%; Gross margin of 52.1%; Current ratio of 1.80 (healthy short-term liquidity); Debt-to-equity of 0.46; Free cash flow per share is positive (5.01); Most recent quarter beat estimates by 13.1%; 5 consecutive earnings beats; EPS growth accelerating (-37.6% -> +33.0% QoQ); Average YoY EPS growth of 19.5%; Analyst estimates falling over recent quarters
Get the Full RVTY Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →